health care

Dr. Jean-Marc F. Blanchard's picture

Killing Chinese Life Sciences, Part I: Poisoning WuXi AppTec and its Kin

In January 2024, Congressman Mike Gallagher, the Chair of the United States (US) House Committee on the Chinese Communist Party, introduced the “Biosecure Act,” which prohibits the US government (USG) from “procuring or obtaining biotechnology equipment or services produced or provided by a biotechnology company of concern,” participating in a c

Second Takes on China’s Foreign Economic Policy after the 2023 Two Sessions and 20th Party Congress

China’s 20th Party Congress in October 2022 and its March 2023 “Two Sessions” revealed the new top leadership of the Chinese Communist Party (CCP), confirmed China’s top government officials, shed light on the CCP’s current agenda, concerns, and dogmas, promulgated new policies, and presented the government’s work program.

Dr. Jean-Marc F. Blanchard's picture

Circling around China’s Dual Circulation Policy, part II-Implications for Inward FDI

In my December blog, I overviewed China’s Dual Circulation System (DCS). To reiterate, foreign multinational corporations (MNCs) are concerned about the DCS’s emphasis on self-sufficiency, indigenous technology, and insulating China against the international market’s vagaries. Foreign MNCs, though, also see opportunities to satiate anticipated growth in domestic demand and the needs of a presumptively wealthier population, facilitate China’s efforts to promote high-quality development through inter alia the provision of “technology-focused products and services” (as one Michelin China CEO put it), and to supply the materials needed for China’s ramped up domestic infrastructure and production.

MNCs in the News-2019-09-13

Despite the United States (US)-China trade war, renowned economist highlights that US firms continue to remain in China because of the attractiveness of China as well as limits associated with the alternatives. During a meeting with a Japanese business delegation, Chinese Premier Li Keqiang welcomes more Japanese foreign direct investment (FDI) in China. Although it decreased compared to 2017, Chinese outward FDI in 2018 was the second highest globally after Japan. China is moving to expand “internet plus healthcare” cooperation with BRI countries generally and BRI countries specifically. Japan’s Fair Trade Commission (FTC) is investigating whether BMW’s Japan subsidiary abused its market power to punish dealers that failed to meet sales quotas. Japan’s trade minister notes South Korea’s filing of a World Trade Organization (WTO) complaint will not affect Japan’s export control measures and that it will decide later if it wants consultations. Korean employer and business groups express worries about government plan to ratify parts of International Labor Organization (ILO) convention which they fear will make Korean labor unions more powerful. Head of LG Chem opines that his company’s lawsuit against SK Innovation in the US does not undermine the national interest.

MNCs in the News-2015-06-19

Foreign direct investment (FDI) in China in May increases by 7.8 percent year-over-year (YOY). New York Times expects Chinese leaders to take heed of foreign business opposition to proposed restrictive Chinese policy measures. Cisco touts plan to invest US $10 billion in China to fund innovation, equity investment, and research and development. China’s National Development and Reform Commission (NDRC) may turn its attention to cases similar to Qualcomm where there is suspect abuse of intellectual property rights (IPR). China’s Ministry of Industry and Information Technology expands opportunities for foreign investors in e-commerce sector. Stabilized bilateral political relations prop up Japanese FDI in China while China’s less appealing economic prospects and labor issues spur a decline. China’s outward FDI continues to surge with massive increases in Chinese FDI in the EU. Australian government touts investment benefits of recently signed China-Australia Free Trade Agreement